Dublin, April 15, 2019 (GLOBE NEWSWIRE) -- The "Cancer Registry Software Market by Type (Standalone, Integration), Delivery (On-premise, Cloud), Database (Commercial, Public), Functionality (Cancer Reporting, Patient Care, Medical Research), End User, Region - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

The cancer patient registry software market is expected to reach USD 91 million by 2024 from USD 55 million in 2019, at a CAGR of 10.4% during the forecast period.

A cancer registry is a computerized database that uses software solutions to organize, collect, and store data on cancer patients to evaluate cancer-specific outcomes, conditions, and drug/medical device exposure. These solutions help store, manage, and provide access to information that helps in building a cancer patient registry.

Growth in this market is mainly driven by the increasing prevalence of cancer & favorable government initiatives, rising pressure to improve the quality of care & reduce healthcare costs, rising adoption of EHRs, and growing use of cancer patient registry data for post-marketing surveillance. On the other hand, factors such as privacy and data security-related concerns may restraint the growth of this market to a certain extent.

In this report, the cancer patient registry software market is segmented in two categories based on type- standalone and integrated software. The standalone software segment accounted for the largest market share in 2018 due to the significant use of standalone software by government organizations & TPAs for population health management due to its adaptability and interoperability.

The integrated software segment is expected to register the highest CAGR of 13.2% during the forecast period. The use of integrated software is increasing in the healthcare industry mainly due to the industry's changing landscape, need to streamline and optimize workflows and decrease physician workloads. In addition, factors such as increasing government focus on population health management, coordinated care, and reducing healthcare costs are boosting market growth.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insight
4.1 Cancer Patient Registry Software: Market Overview
4.2 Market, By Type
4.3 Market, By Deployment Model
4.4 Market, By Database Type
4.5 Market, By Functionality
4.6 Market, By End User

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Prevalence of Cancer and Favorable Government Initiatives
5.2.1.2 Rising Pressure to Improve the Quality of Care and Reduce Healthcare Costs
5.2.1.3 Rising Adoption of Ehrs
5.2.1.4 Growing Use of Cancer Patient Registry Data for Post-Marketing Surveillance
5.2.2 Market Restraints
5.2.2.1 Privacy and Data Security-Related Concerns
5.2.3 Market Opportunities
5.2.3.1 Rising Number of Accountable Care Organizations
5.2.3.2 Growth of Cloud-Based Cancer Patient Registry Solutions
5.2.4 Market Challenges
5.2.4.1 Lack of Interoperability and Integration
5.2.4.2 Reluctance to Adopt Advanced Solutions
5.2.4.3 Lack of Awareness

6 Cancer Patient Registry Software Market, By Type
6.1 Introduction
6.2 Standalone Software
6.2.1 Standalone Software Accounts for the Largest Share of the Market
6.3 Integrated Software
6.3.1 Advantages Such as Flexibility and Safety are Driving the Adoption of Integrated Software

7 Cancer Patient Registry Software Market, By Deployment Model
7.1 Introduction
7.2 On-Premise Models
7.2.1 On-Premise Models Segment Accounted for the Largest Share of the Market in 2018
7.3 Cloud-Based Models
7.3.1 Cost-Effectiveness and Flexibility Have Ensured the Growth of Cloud-Based Models

8 Cancer Patient Registry Software Market, By Database Type
8.1 Introduction
8.2 Commercial Databases
8.2.1 Commercial Databases Segment Hold the Largest Share in the Cancer Patient Registry Software Market
8.3 Public Databases
8.3.1 Public Databases are Used for Data Collection for A Specific Research Agenda

9 Cancer Patient Registry Software Market, By Functionality
9.1 Introduction
9.2 Cancer Reporting to Meet State and Federal Regulations
9.2.1 Stringent and Rapidly Changing State and Federal Regulations for Cancer Reporting to Drive the Growth of This Segment
9.3 Patient Care Management
9.3.1 Market Players are Expected to Focus on Developing Solutions Designed With Automated Patient Outreach Facility for Optimum Patient Care Management
9.4 Medical Research & Clinical Studies
9.4.1 Several Research Organizations are Expected to Support and Encourage the Creation of Registries for Clinical Research
9.5 Product Outcome Evaluation
9.5.1 Product Outcome Evaluation Functionality has Major Applications in Post-Marketing Surveillance in the Pharmaceutical Industry

10 Cancer Patient Registry Software Market, By End User
10.1 Introduction
10.2 Government Organizations & Third-Party Administrators
10.2.1 Growing Government Initiatives to Drive the Demand for Cancer Patient Registry Software in This End-User Segment
10.3 Hospitals & Medical Practices
10.3.1 Improved Patient Care Management Offered By Cancer Patient Registry Software to Drive Its Demand in Hospitals and Medical Practices
10.4 Private Payers
10.4.1 Role of Cancer Patient Registry Software in the Effective Determination of Healthcare Coverage Policies to Drive Its Demand Among Payers
10.5 Pharmaceutical, Biotechnology, and Medical Device Companies
10.5.1 Increased Need for Post-Marketing Surveillance Driving the Demand for Cancer Patient Registry Software in This End-User Segment
10.6 Research Centers
10.6.1 Cancer Patient Registry Software Makes It Easier for Research Centers to Gather Relevant Information on Cancer Patients

11 Cancer Patient Registry Software Market, By Region
11.1 Introduction
11.2 North America
11.2.1 US
11.2.1.1 Rising Adoption of Ehrs and Increased Government Funding to Build Cancer Registries-Key Drivers for Market Growth
11.2.2 Canada
11.2.2.1 Government Initiatives to Encourage Cancer Research and Support Data Collection for Cancer Registries to Contribute to Market Growth
11.3 Europe
11.3.1 UK
11.3.1.1 Initiatives to Promote and Develop Cancer Registration in the UK to Drive the Growth of This Market
11.3.2 Germany
11.3.2.1 Growing Incidence of Cancer and Ongoing Research Activities to Drive Demand for Registry Software
11.3.3 France
11.3.3.1 Growing Emphasis on Healthcare Interoperability to Drive the Market for Integrated Cancer Patient Registry Software in France

12 Competitive Landscape
12.1 Overview
12.2 Market Player Ranking
12.3 Competitive Situation and Trends

13 Company Profiles
13.1 Onco, Inc.
13.2 C/Net Solutions
13.3 Elekta AB (PUB)
13.4 Rocky Mountain Cancer Data Systems
13.5 Electronic Registry Systems, Inc.
13.6 McKesson Corporation

For more information about this report visit https://www.researchandmarkets.com/research/37qtbm/cancer_registry?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.